HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 12, 2023 HUTCHMED Limited refers to its announcement on May 10, 2023 of the appointment of Professor Solange Peters as an Independent. | May 12, 2023
HONG KONG and SHANGHAI, China and FLORHAM PARK, N.J., May 10, 2023 HUTCHMED Limited today announces that Professor Solange Peters is appointed as an Independent Non-executive Director, member. | May 10, 2023
Despite a high-profile clinical disappointment, the TIGIT immune checkpoint remains an important target for anticancer therapy, with research programs testing novel agents moving forward in non–small cell lung cancer and a range of other tumor types.